A Phase II Study of S-1 Combined With Irinotecan and Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gimeracil/oteracil/tegafur; Irinotecan; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms TIROX-2
- 23 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2009 Biomarkers information updated
- 17 Aug 2007 New trial record.